Notably, elevated levels of TRIB3 and NQO1 in blood-derived exosomes may not only serve as promising diagnostic markers for HCC but also hold promise for predicting the efficacy of immunotherapy in HCC patients. The gene discussed is NQO1; the disease is hepatocellular carcinoma.